While the benefits of medical marijuana have been studied since the 1940s, the most groundbreaking discoveries about cannabis and its therapeutic effects have only emerged in the last decade or so as interest in the beneficial properties of medical cannabis has grown.
Recent studies suggest that cannabis, or certain compounds within it, have the potential to:
- Slow the progression of Alzheimer’s and Parkinson’s’ diseases
- Reduce the number and severity of debilitating epileptic seizures
- Reduce muscle spasms experienced by those with multiple sclerosis
- Kill or limit the growth of cancer cells
- Provide anxiety relief and reduce nightmares for those with post-traumatic stress disorder
- Minimize neurological damage following spinal cord and traumatic brain injuries.
In addition, cannabis has been shown to mollify both pain and nausea, making it a potentially powerful therapeutic for numerous medical conditions, including patients having to undergo chemotherapy or traditional AIDS/HIV treatments.
More than 20,000 modern peer-reviewed scientific articles on the pharmacology of cannabis and its cannabinoids have been published by medical journals, further confirming the medicinal properties of marijuana.
Biotech firms in the U.S. and internationally are currently pursuing the development of cannabis-based medicines aimed at a number of conditions, including epilepsy, psoriasis and eczema, and multiple sclerosis, by isolating specific cannabinoids within the cannabis plant for focused relief.
Currently, no other medicine exists to effectively cure any neurodegenerative disease, according to the Institute for Neurodegenerative Diseases. In neurology, pharmaceutical medications target the synapse, wherein the overall neurological network only 2% of all neuronal communication exists. (Source: Electro- Medical Products International). Thus the failure of pharma to adequately address neurological conditions, such as Alzheimer’s, Parkinson’s, depression, neuropathy, etc.
Natural botanical hemp-based CBD seems to carry properties that potentially target a wider range of neuro activities than just the synapse. CBD seems to be activating the entire neural network – well beyond just the synapse. As increasing numbers of anecdotal success stories come in, we aim to understand the process further and then find a true “mechanism of action”. Natural, botanical hemp-based CBD is being studied by the UCSD Center for Regenerative Medicine for its stem-cell-like effects to regenerate new nerves and neuronal cells.
HempMeds believes that that botanical CBD can potentially increase both synaptic density as well as neuronal density within the brain. The importance of this: the hallmark of Alzheimer’s disease is the loss of synaptic density. Should we be able to reverse this and rebuild synaptic density in elderly patients – especially with a natural botanical remedy that is non-pharmaceutical, no side effects – this would be a huge step forward in neurological medicine, as well as tremendous for humanity and the future quality of life for many of our senior citizens. As shown in animal studies that when synaptic density increases, so does cognition / cognitive function.
The Mechanism of Action (MOA) we feel is linked to improved mitochondrial function – which we have already seen with CBD. Cannabidiol (CBD) Targets Mitochondria to Regulate Intercellular Calcium Levels. If we are successful future patients may be able to avoid the long term devastation of Alzheimer’s – saving the US Government healthcare system over $1.1 trillion, as predicted spending on Alzheimer’s is on track for by the year 2050.
It can be as simple as taking CBD oil to prevent aging, heal cancer, and provide overall wellness for the body.
To read more about CBD oil, click here.
To get CBD oil, email firstname.lastname@example.org.